Out of 1,119 health workers (doctors, nurses, laboratory assistants, etc.) who took part in the survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik, 66% have already been vaccinated from COVID-19 (Fig. 1). Another 12% have not yet had time to get vaccinated, but are willing to do it in the near future.

Between Q1 and Q2 2021, the sales of veterinary drugs in the Russian retail market amounted to 11 billion rubles (retail prices, VAT included), up only 3.8% in monetary terms (rubles) from 2020, which is much lower than the inflation rate of 8.3%. In physical terms, the market volume amounted to 93 million minimum dosage units (MDU), with the growth rates of +3.1%.

Between January and May 2021, Russian manufacturers produced 239.1 billion rubles worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 26% from the same period last year in monetary terms (rubles). The growth rate in physical terms (packages), however, is still negative, -9.2%, with the production volume of 1.7 billion packages. Despite the serious drop in packages, the growth rate in MDUs (minimum dosage units) is much better: -1.7%, 32.6 billion MDUs produced. Apart from the falling demand, the standard package has changed.